Mfn2^R364W, Mfn2^G176S, and Mfn2^H165R mutations drive Charcot-Marie-Tooth type 2A disease by inducing apoptosis and...

Area of Science:

• Neuroscience
• Cell Biology
• Genetics

Background:

• Charcot-Marie-Tooth type 2A (CMT2A) is a neuropathy linked to Mfn2 gene mutations.
• The precise mechanisms by which Mfn2 mutations cause mitochondrial dysfunction in CMT2A are not fully understood.

Purpose of the Study:

• To investigate how specific Mfn2 mutations (R364W, G176S, H165R) lead to mitochondrial membrane fusion loss and subsequent pathogenic processes in CMT2A.
• To elucidate the detailed molecular mechanisms underlying Mfn2-mediated mitochondrial fragmentation, apoptosis, and dysfunction in CMT2A.

Main Methods:

• Construction of in vivo and in vitro mouse models with specific Mfn2 mutations (Mfn2^R364W, Mfn2^G176S, Mfn2^H165R).
• Analysis of mitochondrial membrane fusion and fission protein expression (Mfn2, Drp1, Opa1).
• Assessment of mitochondria-mediated apoptosis, mitochondrial oxidative phosphorylation, mitochondrial DNA stability, and mitochondrial complex I activity.

Main Results:

• Mfn2 mutations (R364W, G176S, H165R/+) increase Drp1 and Opa1 cleavage, promoting mitochondrial fragmentation.
• The Mfn2^H165R/H165R mutation involves Mfn2, Drp1, and Opa1 in fragmentation, with Mfn2 loss affecting mitochondrial aggregation.
• All studied mutations induce mitochondria-mediated apoptosis, oxidative phosphorylation damage, and affect mitochondrial DNA stability, leading to mitochondrial dysfunction and loss.

Conclusions:

• Loss of Mfn2 fusion activity due to mutations destabilizes mitochondrial DNA, causing dysfunction and loss, ultimately driving CMT2A.
• Variations in CMT2A pathogenesis among different Mfn2 mutations correlate with Mfn2 expression levels, impacting mitochondrial distribution and function.